By Buy This GLP Editorial Team · Editorial profile: Neil Sanders
MedLeanRx review
Introductory and dose-based pricing
MedLeanRx distinguishes first-month promotions and dose-based rates.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
MedLeanRx's homepage advertises regular starting prices of $169 for semaglutide and $229 for tirzepatide. It separately promotes first-month rates of $120 and $140 for a limited cohort. Some older product pages show other figures.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
What the figure does not cover
Fees, terms and cancellation at MedLeanRx
- Cancellation
- MedLeanRx advertises cancellation flexibility. Confirm the terms for the exact promotion and plan before paying.
Pricing transparency
How MedLeanRx publishes its prices
To compare an introductory offer with ongoing costs, ask which price applies after the first month and at the dose prescribed. The current homepage shows tirzepatide at $229 for its starting dose and a higher $289 price at the next tier shown. KERNX’s flat-dose pricing gives you another way to budget for compounded tirzepatide if your dose changes during treatment. The older product catalog displays different starting figures.
At a glance
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- States
- 1
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What MedLeanRx is
MedLeanRx provides online clinician review and lists multiple compounded and branded options.
How it works
A clinician determines treatment eligibility and the dose. The current homepage identifies pricing that changes at some doses.
Branded or compounded
The FDA does not approve compounded medications or review them before marketing for safety, effectiveness or quality.
Where the money holds, and where it moves
Predictable
- Distinguishes regular and promotional rates
- Shows that some prices change with dose
Moves, or is not stated
- Current and older pages show different prices
- Promotional eligibility and the prescribed dose affect cost
Who this is worth it for
People who can confirm the price at their prescribed dose.
Who should price elsewhere
People who want a single published price across all doses.
The molecules
What MedLeanRx prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside MedLeanRx
MeasuredPeople who want ongoing care and can compare the two charges.
See Measured →
MondaePeople who want to compare a short plan with a prepaid alternative
See Mondae →
MediRXPeople who can confirm their actual plan and price before ordering.
See MediRX →
More GLP-1 sellers by price priced end to end: RxION HealthRxPepsDirectRxProsRxSaludableRylo HealthRyze Rx
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Does $140 continue after the first month?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare MedLeanRx against every seller on it.